Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer
about
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerThe cancer stem cell: evidence for its origin as an injured autoreactive T cellSelective Estrogen Receptor ModulatorsWhat is the Best Treatment for a Cancer Patient with Thrombosis?Cerebral ischemic events in patients with pancreatic cancer: A retrospective cohort study of 17 patients and a literature reviewThe hypercoagulable state of malignancy: pathogenesis and current debateCardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast GroupTamoxifen and risk of idiopathic venous thromboembolismPharmacology and clinical applications of selective estrogen receptor modulators.Drug-induced hematologic syndromesCancer-associated thrombosis.Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.Arterial and venous thrombosis in cancer patientsCisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature.Designing the ideal selective estrogen receptor modulator--an achievable goal?SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.Association between incident cancer and subsequent stroke.Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.A case of dural arteriovenous fistula of superior sagittal sinus after tamoxifen treatment for breast cancer.Combined pulmonary venous thromboembolism and renal artery thrombosis in a patient with non-small cell lung cancerConcurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.Tamoxifen-associated vasculitis in a breast cancer patient.Epidemiology and pathophysiology of cancer-associated thrombosis.Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score.Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal womenManagement of cancer-associated venous thrombosis.Deep vein thrombosis in cancer: the scale of the problem and approaches to management.Breast cancer as an acquired thrombophilic state.Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient.Approach to chemotherapy-associated thrombosis.Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patientsThromboembolism in cancer patients: pathogenesis and treatment.Venous thromboembolic disease and cancerDevelopment and validation of a predictive model for chemotherapy-associated thrombosis.Assessing risk of venous thromboembolism in the patient with cancer.Supportive care in hemato-oncology: a review in light of the latest guidelines.Thromboembolic disease in cancer patients.Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis.
P2860
Q24633010-14F92F06-46BF-4F98-89AD-1396F197BA91Q24685693-1DE2D7B8-83A9-4E2D-BF37-C5648ECA563DQ25256839-EDB95DBE-E04B-4D38-B2F3-42C58F6CEF40Q26738923-B6E832BA-B19B-4B0A-8DD7-BC827F6E6160Q27009514-8D60B1C9-885F-4F17-9FF5-EAB189A9E190Q27314885-3B2E6532-E8D4-41F3-88B6-DB367072B0DFQ28212265-4C6F0FE3-05E1-4F4F-B3BD-4FA75E4A3A6BQ28367785-77A7F663-C899-4236-A542-F8E45699D38EQ28368257-60DCBEDB-DCE5-4CA4-A900-04396B1F3AA2Q33384192-80951837-93AB-430D-A1C1-5D97984ABE76Q33387312-10D10B99-4FB9-4DDB-ABE5-2579161924B8Q33389006-F24E9332-FBDD-4771-9427-D7B4ED4C4CA8Q34130749-8E043DEE-9217-41D9-B54F-40181ADAE960Q34635182-8CF615B7-7B0E-4326-A1AF-BC332874C1C9Q34899063-8E786871-5563-4DD9-837E-825E6BC58CA7Q35023776-FFF2C21B-2077-4B43-BBBD-D9EA812A5C9BQ35028647-11754565-2CC6-478D-AC9B-F68EAC5E1784Q35044297-52EC78D1-2A16-4F84-9A7E-E8F83EAC7C49Q35091342-F031E37A-82DF-4DD9-83A8-1409EDF3FDD9Q35215567-F63AF25D-5E28-43FE-8464-0E78489379F9Q35227708-B90B0F69-3626-453F-B815-5E335E4AFB46Q35460114-BE37E5D3-9475-43FB-A006-882761B0561EQ35613567-C96FFCC2-454B-491E-8F70-F89DC5D13427Q35860789-8DBD3FFF-59B1-4AE8-A5B5-BD458A67F308Q35861679-5A650135-8E61-4FF5-B3F4-AE8BFF15EA16Q35993211-211804B4-4A52-4916-957E-4F5179803F02Q36013024-F1884EA3-166E-40D4-925E-BF1F1056673CQ36085302-660FE5E1-FB5B-4B4D-81DB-CC5551B53024Q36092001-1B733584-37EF-4F0F-99EF-28D8CA3DD466Q36265574-26E14A23-FCBA-47F9-B0B6-E7A5D65F9170Q36304793-AF445719-459B-4C6C-B7AD-F2483D0E4FECQ36352053-AF3D2CAD-6C09-49A0-8616-5733C191A284Q36536307-92F5EC35-A8C9-41A3-BE7C-1358E09DDD6EQ36588644-C64DCC63-093E-4738-86E4-EEEC1F29CE31Q36636027-E6CA4DE8-88DD-4E59-8D5C-5BEE6CE576B6Q36657982-BBC03E8E-B102-4A25-A3F5-661E5E3CF6DCQ37393394-FAFDDC88-FBB6-4E88-A033-2F04B32F6D3FQ37702827-28772622-81F9-4C8B-AEBC-6CC3D5661658Q38083556-A70120F3-43DC-447F-83DD-23EBDCC2E618Q38968554-2330876B-3962-46CC-8EBD-458D26679979
P2860
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer
description
1991 nî lūn-bûn
@nan
1991 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Venous and arterial thrombosis ...... vant therapy for breast cancer
@ast
Venous and arterial thrombosis ...... vant therapy for breast cancer
@en
Venous and arterial thrombosis ...... vant therapy for breast cancer
@nl
type
label
Venous and arterial thrombosis ...... vant therapy for breast cancer
@ast
Venous and arterial thrombosis ...... vant therapy for breast cancer
@en
Venous and arterial thrombosis ...... vant therapy for breast cancer
@nl
prefLabel
Venous and arterial thrombosis ...... vant therapy for breast cancer
@ast
Venous and arterial thrombosis ...... vant therapy for breast cancer
@en
Venous and arterial thrombosis ...... vant therapy for breast cancer
@nl
P2093
P3181
P356
P1476
Venous and arterial thrombosis ...... vant therapy for breast cancer
@en
P2093
P304
P3181
P356
10.1200/JCO.1991.9.2.286
P407
P577
1991-02-01T00:00:00Z